Rajwant Sodhi - Jan 4, 2022 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
s/ David B. Berger, Attorney-in-Fact for Rajwant S. Sodhi
Stock symbol
TNDM
Transactions as of
Jan 4, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 06:17 PM
Previous filing
Oct 14, 2021
Next filing
May 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +1.07K $0.00 1.07K Jan 4, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 +1.07K +99.91% $0.00 2.14K Jan 4, 2022 Common Stock 1.07K Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.
F3 This RSU award was granted on January 4, 2021. 33% of the RSU vested on January 4, 2022 and the remaining 67% will vest annually over the next two years.
F4 The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.